Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Peter Oppelt

3PUBLICATIONS

48CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Mar 24, 2025

Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer.

Patrick M Grierson, Crystal Wolf, Rama Suresh

|Jun 26, 2023

A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor.

Suzanne George, Michael C Heinrich, Neeta Somaiah

|Dec 22, 2022

A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma.

Matthew Ingham, Shing Lee, Brian A Van Tine

Pageof 1

Frequent Collaborators

1 joint publications

Matthew Ingham

1 joint publications

Shing Lee

1 joint publications

Brian A Van Tine

1 joint publications

Edwin Choy

1 joint publications

Jay Oza

1 joint publications

Sahil Doshi

1 joint publications

Liner Ge

1 joint publications

Gregory Cote

1 joint publications

Brian Corgiat

1 joint publications

Naomi Sender

Frequent Collaborators

1 joint publications

Matthew Ingham

1 joint publications

Shing Lee

1 joint publications

Brian A Van Tine

1 joint publications

Edwin Choy

Top Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on : Apr 11, 2018

See more related videos

Top Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on : Apr 11, 2018

See more related videos